【EFPIA】Annex 3 Industrial Use Of Fluoropolymers In Pharma Manufacturing Final.pdf

Web annex E: Oxygen supplier’s mapping

WEF_HE_HealthyLiving_Toolkit_Annex_2013

CCS_Annex

WHO Global Model Regulatory Framework for medical devices including in vitro diagnostic medical devices, Annex 3

Switzerland: 2024 Article IV Consultation-Press Release; Staff Report; Informational Annex; and Statement by the Executive Director for Switzerland

Explanatory Note on Annexe 7 to the Regulations on the Status and Transfer of Players

Annex 1 Socio-Economic Analysis Of the potential restriction of the perand polyfluoroalkyl substances (PFAS) used in the production, packaging and delivery of human medicinal products

Annex 2 Patient Impact Survey Human Health Associations

Saudi Arabia: 2023 Article IV Consultation-Press Release; Staff Report; and Informational Annex

Recommendations to assure the quality, safety and efficacy of poliomyelitis vaccines (oral, live, attenuated), Annex 2